Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Jun'23
Mar'23
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Operating Income
435.43
1,152.13
1,737.64
856.93
768.35
1,140.23
2,168.41
Total Operating income
4,354.27
11,521.34
17,376.36
8,569.28
7,683.45
11,402.31
21,684.12
Raw Material Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
284.03
755.20
1,104.16
582.42
939.83
1,312.30
2,055.88
Other Expenses
392.92
1,106.67
1,642.15
935.78
696.95
1,059.07
1,949.79
Total Expenditure (Excl Depreciation)
4,213.28
11,821.93
17,525.64
9,940.22
7,909.29
11,902.98
21,553.82
Operating Profit (PBDIT) excl Other Income
141
-300.59999999999997
-149.3
-1370.9
-225.79999999999998
-500.7
130.29999999999998
Other Income
-12.83
-20.71
-3.06
-9.00
-8.47
17.42
-5.68
Operating Profit (PBDIT)
-12.83
-20.71
-3.06
33.09
33.62
57.93
34.83
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
42.09
42.09
40.51
40.51
Profit Before Tax
128.15
-321.30
-152.34
-1,379.94
-234.31
-483.25
124.61
Tax
87.21
230.00
45.34
-559.21
-117.24
24.48
65.47
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
31.92
-275.15
-89.88
-438.76
-25.60
-232.60
45.21
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
31.92
-275.15
-89.88
-438.76
-25.60
-232.60
45.21
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
34.78
-263.80
-82.34
-423.30
-19.68
-226.29
39.53
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
66.70
-538.95
-172.21
-862.06
-45.27
-458.90
84.73
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
21,799.55
20,460.97
20,546.54
20,590.06
20,624.11
20,909.38
21,747.01
Earnings per share (EPS)
0.01
-0.06
-0.02
-0.09
-0.01
-0.05
0.01
Diluted Earnings per share
0.01
-0.06
-0.02
-0.09
-0.01
-0.05
0.01
Operating Profit Margin (Excl OI)
3.24%
-2.61%
-0.86%
-16.0%
-2.94%
-4.39%
0.6%
Gross Profit Margin
2.94%
-2.79%
-0.88%
-15.61%
-2.5%
-3.88%
0.76%
PAT Margin
0.73%
-2.39%
-0.52%
-5.12%
-0.33%
-2.04%
0.21%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2024 is 0.00% vs 0.00% in Jun 2024
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2024 is 112.38% vs -212.95% in Jun 2024
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2024 is 0.00% vs 0.00% in Jun 2024
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2024 has improved from Jun 2024
Compare Quarterly Results Of Hubei Biocause Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
0
0
0.00
Other Operating Income
4,354.27
0.00
4,354.27
Total Operating income
4,354.27
0
4,354.27
Raw Material Cost
0
0
0.00
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
284.03
0
284.03
Other Expenses
392.92
0.00
392.92
Total Expenditure (Excl Depreciation)
4,213.28
0
4,213.28
Operating Profit (PBDIT) excl Other Income
140.99
0.00
140.99
Other Income
-12.83
0
-12.83
Operating Profit (PBDIT)
-12.83
0
-12.83
Interest
0.00
0
0.00
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
0.00
0
0.00
Depreciation
0.00
0
0.00
Profit Before Tax
128.15
0
128.15
Tax
87.21
0
87.21
Provisions and contingencies
0
0
0.00
Profit After Tax
31.92
0
31.92
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
31.92
0
31.92
Share in Profit of Associates
0
0
0.00
Minority Interest
34.78
0
34.78
Other related items
0.00
0.00
0.00
Consolidated Net Profit
66.70
0
66.70
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
21,799.55
0
21,799.55
Earnings per share (EPS)
0.01
0
0.01
Diluted Earnings per share
0.01
0
0.01
Operating Profit Margin (Excl OI)
3.24%
0%
0.00
3.24%
Gross Profit Margin
2.94%
0%
0.00
2.94%
PAT Margin
0.73%
0%
0.00
0.73%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
No Net Sales in the last few periods
Quarterly - Consolidate Net Profit
Consolidate Net Profit 6.67 Million
in Sep 2024Figures in Million
QoQ Growth in quarter ended Sep 2024 is 112.38% vs -212.95% in Jun 2024
YoY Growth in quarter ended Sep 2024 is 247.24% vs -139.98% in Sep 2023
Quarterly - Operating Profit (PBDIT)
No Operating Profit (PBDIT) in the last few periods
Quarterly - Interest
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.24%
in Sep 2024Figures in %
QoQ Growth in quarter ended Sep 2024 has improved from Jun 2024
YoY Growth in quarter ended Sep 2024 has improved from Sep 2023






